These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 36494783)

  • 1. PRState: Incorporating genetic ancestry in prostate cancer risk scores for men of African ancestry.
    Pagadala MS; Linscott JA; Talwar JV; Seibert TM; Rose B; Lynch J; Panizzon M; Hauger R; Hansen MH; Sammon JD; Hayn MH; Kader K; Carter H; Ryan ST
    BMC Cancer; 2022 Dec; 22(1):1289. PubMed ID: 36494783
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Validation of a prostate cancer polygenic risk score.
    Black MH; Li S; LaDuca H; Lo MT; Chen J; Hoiness R; Gutierrez S; Tippin-Davis B; Lu HM; Gielzak M; Wiley K; Shi Z; Wei J; Zheng SL; Helfand BT; Isaacs W; Xu J
    Prostate; 2020 Nov; 80(15):1314-1321. PubMed ID: 33258481
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluating approaches for constructing polygenic risk scores for prostate cancer in men of African and European ancestry.
    Darst BF; Shen J; Madduri RK; Rodriguez AA; Xiao Y; Sheng X; Saunders EJ; Dadaev T; Brook MN; Hoffmann TJ; Muir K; Wan P; Le Marchand L; Wilkens L; Wang Y; Schleutker J; MacInnis RJ; Cybulski C; Neal DE; Nordestgaard BG; Nielsen SF; Batra J; Clements JA; Cancer BioResource AP; Grönberg H; Pashayan N; Travis RC; Park JY; Albanes D; Weinstein S; Mucci LA; Hunter DJ; Penney KL; Tangen CM; Hamilton RJ; Parent MÉ; Stanford JL; Koutros S; Wolk A; Sørensen KD; Blot WJ; Yeboah ED; Mensah JE; Lu YJ; Schaid DJ; Thibodeau SN; West CM; Maier C; Kibel AS; Cancel-Tassin G; Menegaux F; John EM; Grindedal EM; Khaw KT; Ingles SA; Vega A; Rosenstein BS; Teixeira MR; ; Kogevinas M; Cannon-Albright L; Huff C; Multigner L; Kaneva R; Leach RJ; Brenner H; Hsing AW; Kittles RA; Murphy AB; Logothetis CJ; Neuhausen SL; Isaacs WB; Nemesure B; Hennis AJ; Carpten J; Pandha H; De Ruyck K; Xu J; Razack A; Teo SH; ; Newcomb LF; Fowke JH; Neslund-Dudas C; Rybicki BA; Gamulin M; Usmani N; Claessens F; Gago-Dominguez M; Castelao JE; Townsend PA; Crawford DC; Petrovics G; Casey G; Roobol MJ; Hu JF; Berndt SI; Van Den Eeden SK; Easton DF; Chanock SJ; Cook MB; Wiklund F; Witte JS; Eeles RA; Kote-Jarai Z; Watya S; Gaziano JM; Justice AC; Conti DV; Haiman CA
    Am J Hum Genet; 2023 Jul; 110(7):1200-1206. PubMed ID: 37311464
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Validation of a multi-ancestry polygenic risk score and age-specific risks of prostate cancer: A meta-analysis within diverse populations.
    Chen F; Darst BF; Madduri RK; Rodriguez AA; Sheng X; Rentsch CT; Andrews C; Tang W; Kibel AS; Plym A; Cho K; Jalloh M; Gueye SM; Niang L; Ogunbiyi OJ; Popoola O; Adebiyi AO; Aisuodionoe-Shadrach OI; Ajibola HO; Jamda MA; Oluwole OP; Nwegbu M; Adusei B; Mante S; Darkwa-Abrahams A; Mensah JE; Adjei AA; Diop H; Lachance J; Rebbeck TR; Ambs S; Gaziano JM; Justice AC; Conti DV; Haiman CA
    Elife; 2022 Jul; 11():. PubMed ID: 35801699
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A genome-wide association study of prostate cancer in Latinos.
    Du Z; Hopp H; Ingles SA; Huff C; Sheng X; Weaver B; Stern M; Hoffmann TJ; John EM; Van Den Eeden SK; Strom S; Leach RJ; Thompson IM; Witte JS; Conti DV; Haiman CA
    Int J Cancer; 2020 Apr; 146(7):1819-1826. PubMed ID: 31226226
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evidence of Novel Susceptibility Variants for Prostate Cancer and a Multiancestry Polygenic Risk Score Associated with Aggressive Disease in Men of African Ancestry.
    Chen F; Madduri RK; Rodriguez AA; Darst BF; Chou A; Sheng X; Wang A; Shen J; Saunders EJ; Rhie SK; Bensen JT; Ingles SA; Kittles RA; Strom SS; Rybicki BA; Nemesure B; Isaacs WB; Stanford JL; Zheng W; Sanderson M; John EM; Park JY; Xu J; Wang Y; Berndt SI; Huff CD; Yeboah ED; Tettey Y; Lachance J; Tang W; Rentsch CT; Cho K; Mcmahon BH; Biritwum RB; Adjei AA; Tay E; Truelove A; Niwa S; Sellers TA; Yamoah K; Murphy AB; Crawford DC; Patel AV; Bush WS; Aldrich MC; Cussenot O; Petrovics G; Cullen J; Neslund-Dudas CM; Stern MC; Kote-Jarai Z; Govindasami K; Cook MB; Chokkalingam AP; Hsing AW; Goodman PJ; Hoffmann TJ; Drake BF; Hu JJ; Keaton JM; Hellwege JN; Clark PE; Jalloh M; Gueye SM; Niang L; Ogunbiyi O; Idowu MO; Popoola O; Adebiyi AO; Aisuodionoe-Shadrach OI; Ajibola HO; Jamda MA; Oluwole OP; Nwegbu M; Adusei B; Mante S; Darkwa-Abrahams A; Mensah JE; Diop H; Van Den Eeden SK; Blanchet P; Fowke JH; Casey G; Hennis AJ; Lubwama A; Thompson IM; Leach R; Easton DF; Preuss MH; Loos RJ; Gundell SM; Wan P; Mohler JL; Fontham ET; Smith GJ; Taylor JA; Srivastava S; Eeles RA; Carpten JD; Kibel AS; Multigner L; Parent MÉ; Menegaux F; Cancel-Tassin G; Klein EA; Andrews C; Rebbeck TR; Brureau L; Ambs S; Edwards TL; Watya S; Chanock SJ; Witte JS; Blot WJ; Michael Gaziano J; Justice AC; Conti DV; Haiman CA
    Eur Urol; 2023 Jul; 84(1):13-21. PubMed ID: 36872133
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genetic variants demonstrating flip-flop phenomenon and breast cancer risk prediction among women of African ancestry.
    Wang S; Qian F; Zheng Y; Ogundiran T; Ojengbede O; Zheng W; Blot W; Nathanson KL; Hennis A; Nemesure B; Ambs S; Olopade OI; Huo D
    Breast Cancer Res Treat; 2018 Apr; 168(3):703-712. PubMed ID: 29302764
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Polygenic risk scores for the prediction of common cancers in East Asians: A population-based prospective cohort study.
    Ho PJ; Tan IB; Chong DQ; Khor CC; Yuan JM; Koh WP; Dorajoo R; Li J
    Elife; 2023 Mar; 12():. PubMed ID: 36971353
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterization of SNPs associated with prostate cancer in men of Ashkenazic descent from the set of GWAS identified SNPs: impact of cancer family history and cumulative SNP risk prediction.
    Agalliu I; Wang Z; Wang T; Dunn A; Parikh H; Myers T; Burk RD; Amundadottir L
    PLoS One; 2013; 8(4):e60083. PubMed ID: 23573233
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The PROFILE Feasibility Study: Targeted Screening of Men With a Family History of Prostate Cancer.
    Castro E; Mikropoulos C; Bancroft EK; Dadaev T; Goh C; Taylor N; Saunders E; Borley N; Keating D; Page EC; Saya S; Hazell S; Livni N; deSouza N; Neal D; Hamdy FC; Kumar P; Antoniou AC; Kote-Jarai Z; ; Eeles RA
    Oncologist; 2016 Jun; 21(6):716-22. PubMed ID: 27151655
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Performance of polygenic risk scores for cancer prediction in a racially diverse academic biobank.
    Wang L; Desai H; Verma SS; Le A; Hausler R; Verma A; Judy R; Doucette A; Gabriel PE; ; Nathanson KL; Damrauer SM; Mowery DL; Ritchie MD; Kember RL; Maxwell KN
    Genet Med; 2022 Mar; 24(3):601-609. PubMed ID: 34906489
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Application of European-specific polygenic risk scores for predicting prostate cancer risk in different ancestry populations.
    Ruan X; Huang D; Huang J; Xu D; Na R
    Prostate; 2023 Jan; 83(1):30-38. PubMed ID: 35996327
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prevalence of the HOXB13 G84E germline mutation in British men and correlation with prostate cancer risk, tumour characteristics and clinical outcomes.
    Kote-Jarai Z; Mikropoulos C; Leongamornlert DA; Dadaev T; Tymrakiewicz M; Saunders EJ; Jones M; Jugurnauth-Little S; Govindasami K; Guy M; Hamdy FC; Donovan JL; Neal DE; Lane JA; Dearnaley D; Wilkinson RA; Sawyer EJ; Morgan A; Antoniou AC; Eeles RA;
    Ann Oncol; 2015 Apr; 26(4):756-761. PubMed ID: 25595936
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Self-Identified African Americans and prostate cancer risk: West African genetic ancestry is associated with prostate cancer diagnosis and with higher Gleason sum on biopsy.
    Grizzle WE; Kittles RA; Rais-Bahrami S; Shah E; Adams GW; DeGuenther MS; Kolettis PN; Nix JW; Bryant JE; Chinsky R; Kearns JE; Dehimer K; Terrin N; Chang H; Gaston SM
    Cancer Med; 2019 Nov; 8(16):6915-6922. PubMed ID: 31568648
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association analyses of more than 140,000 men identify 63 new prostate cancer susceptibility loci.
    Schumacher FR; Al Olama AA; Berndt SI; Benlloch S; Ahmed M; Saunders EJ; Dadaev T; Leongamornlert D; Anokian E; Cieza-Borrella C; Goh C; Brook MN; Sheng X; Fachal L; Dennis J; Tyrer J; Muir K; Lophatananon A; Stevens VL; Gapstur SM; Carter BD; Tangen CM; Goodman PJ; Thompson IM; Batra J; Chambers S; Moya L; Clements J; Horvath L; Tilley W; Risbridger GP; Gronberg H; Aly M; Nordström T; Pharoah P; Pashayan N; Schleutker J; Tammela TLJ; Sipeky C; Auvinen A; Albanes D; Weinstein S; Wolk A; Håkansson N; West CML; Dunning AM; Burnet N; Mucci LA; Giovannucci E; Andriole GL; Cussenot O; Cancel-Tassin G; Koutros S; Beane Freeman LE; Sorensen KD; Orntoft TF; Borre M; Maehle L; Grindedal EM; Neal DE; Donovan JL; Hamdy FC; Martin RM; Travis RC; Key TJ; Hamilton RJ; Fleshner NE; Finelli A; Ingles SA; Stern MC; Rosenstein BS; Kerns SL; Ostrer H; Lu YJ; Zhang HW; Feng N; Mao X; Guo X; Wang G; Sun Z; Giles GG; Southey MC; MacInnis RJ; FitzGerald LM; Kibel AS; Drake BF; Vega A; Gómez-Caamaño A; Szulkin R; Eklund M; Kogevinas M; Llorca J; Castaño-Vinyals G; Penney KL; Stampfer M; Park JY; Sellers TA; Lin HY; Stanford JL; Cybulski C; Wokolorczyk D; Lubinski J; Ostrander EA; Geybels MS; Nordestgaard BG; Nielsen SF; Weischer M; Bisbjerg R; Røder MA; Iversen P; Brenner H; Cuk K; Holleczek B; Maier C; Luedeke M; Schnoeller T; Kim J; Logothetis CJ; John EM; Teixeira MR; Paulo P; Cardoso M; Neuhausen SL; Steele L; Ding YC; De Ruyck K; De Meerleer G; Ost P; Razack A; Lim J; Teo SH; Lin DW; Newcomb LF; Lessel D; Gamulin M; Kulis T; Kaneva R; Usmani N; Singhal S; Slavov C; Mitev V; Parliament M; Claessens F; Joniau S; Van den Broeck T; Larkin S; Townsend PA; Aukim-Hastie C; Gago-Dominguez M; Castelao JE; Martinez ME; Roobol MJ; Jenster G; van Schaik RHN; Menegaux F; Truong T; Koudou YA; Xu J; Khaw KT; Cannon-Albright L; Pandha H; Michael A; Thibodeau SN; McDonnell SK; Schaid DJ; Lindstrom S; Turman C; Ma J; Hunter DJ; Riboli E; Siddiq A; Canzian F; Kolonel LN; Le Marchand L; Hoover RN; Machiela MJ; Cui Z; Kraft P; Amos CI; Conti DV; Easton DF; Wiklund F; Chanock SJ; Henderson BE; Kote-Jarai Z; Haiman CA; Eeles RA; ; ; ; ; ; ; ; ;
    Nat Genet; 2018 Jul; 50(7):928-936. PubMed ID: 29892016
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genetic predisposition to prostate cancer.
    Benafif S; Eeles R
    Br Med Bull; 2016 Dec; 120(1):75-89. PubMed ID: 27941040
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association between genetically proxied PCSK9 inhibition and prostate cancer risk: A Mendelian randomisation study.
    Fang S; Yarmolinsky J; Gill D; Bull CJ; Perks CM; ; Davey Smith G; Gaunt TR; Richardson TG
    PLoS Med; 2023 Jan; 20(1):e1003988. PubMed ID: 36595504
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Common genetic variants associated with disease from genome-wide association studies are mutually exclusive in prostate cancer and rheumatoid arthritis.
    Orozco G; Goh CL; Al Olama AA; Benlloch-Garcia S; Govindasami K; Guy M; Muir KR; Giles GG; Severi G; Neal DE; Hamdy FC; Donovan JL; Kote-Jarai Z; Easton DF; Eyre S; Eeles RA
    BJU Int; 2013 Jun; 111(7):1148-55. PubMed ID: 22985493
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genome-wide association study in individuals of European and African ancestry and multi-trait analysis of opioid use disorder identifies 19 independent genome-wide significant risk loci.
    Deak JD; Zhou H; Galimberti M; Levey DF; Wendt FR; Sanchez-Roige S; Hatoum AS; Johnson EC; Nunez YZ; Demontis D; Børglum AD; Rajagopal VM; Jennings MV; Kember RL; Justice AC; Edenberg HJ; Agrawal A; Polimanti R; Kranzler HR; Gelernter J
    Mol Psychiatry; 2022 Oct; 27(10):3970-3979. PubMed ID: 35879402
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluating Approaches for Constructing Polygenic Risk Scores for Prostate Cancer in Men of African and European Ancestry.
    Darst BF; Shen J; Madduri RK; Rodriguez AA; Xiao Y; Sheng X; Saunders EJ; Dadaev T; Brook MN; Hoffmann TJ; Muir K; Wan P; Le Marchand L; Wilkens L; Wang Y; Schleutker J; MacInnis RJ; Cybulski C; Neal DE; Nordestgaard BG; Nielsen SF; Batra J; Clements JA; ; Grönberg H; Pashayan N; Travis RC; Park JY; Albanes D; Weinstein S; Mucci LA; Hunter DJ; Penney KL; Tangen CM; Hamilton RJ; Parent MÉ; Stanford JL; Koutros S; Wolk A; Sørensen KD; Blot WJ; Yeboah ED; Mensah JE; Lu YJ; Schaid DJ; Thibodeau SN; West CM; Maier C; Kibel AS; Cancel-Tassin G; Menegaux F; John EM; Grindedal EM; Khaw KT; Ingles SA; Vega A; Rosenstein BS; Teixeira MR; ; Kogevinas M; Cannon-Albright L; Huff C; Multigner L; Kaneva R; Leach RJ; Brenner H; Hsing AW; Kittles RA; Murphy AB; Logothetis CJ; Neuhausen SL; Isaacs WB; Nemesure B; Hennis AJ; Carpten J; Pandha H; De Ruyck K; Xu J; Razack A; Teo SH; ; Newcomb LF; Fowke JH; Neslund-Dudas C; Rybicki BA; Gamulin M; Usmani N; Claessens F; GagoDominguez M; Castelao JE; Townsend PA; Crawford DC; Petrovics G; Casey G; Roobol MJ; Hu JF; Berndt SI; Van Den Eeden SK; Easton DF; Chanock SJ; Cook MB; Wiklund F; Witte JS; Eeles RA; Kote-Jarai Z; Watya S; Gaziano JM; Justice AC; Conti DV; Haiman CA
    medRxiv; 2023 May; ():. PubMed ID: 37292833
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.